Teva- Pharmaceutical Industries Ltd

NYSE: TEVA
$18.77
+$0.13 (+0.7%)
Closing Price on November 5, 2024

TEVA Articles

The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Teva Pharmaceutical Industries released its most recent quarterly report before the markets opened on Thursday.
24/7 Wall St. has put together a preview of Alibaba, CVS, Tesla and some of the other most anticipated earnings reports due in the coming week.
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Credit Suisse's fresh contrarian picks include Cleveland-Cliffs, Ralph Lauren and Teva Pharmaceutical Industries.
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
24/7 Wall St. has tracked many of the so-called whale watching trades made by America's top investment managers, hedge fund managers and independent investors.
The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The top analyst upgrades, downgrades and other research calls from Friday include AIG, Expedia, FireEye, Nvidia, 3D Systems, Teva Pharmaceutical, Twitter, Disney, Wayfair and Wynn Resorts.
The January 12 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The December 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Judging by the most shorted stocks traded on the New York Stock Exchange, short sellers were mostly ready to lighten up on those stocks between the December 15 and December 29 settlement dates.